Clinical trial · Interventional
Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery.
NCT03924804CI-TRIAL-00058484completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of the trial was to explore the effect of different infusion volume on perioperative bladder and blood volume in patients undergoing daytime surgery assisted by bladder and vascular ultrasound and transthoracic echocardiography.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cholecystolithiasis and Thyroid Nodule | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ringer's solution acetate | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Group A: 2 ml/kg group
- interventionNames
- Drug: Ringer's solution acetate
- type
- EXPERIMENTAL
- label
- Group B: 8 ml/kg group
- interventionNames
- Drug: Ringer's solution acetate
- type
- EXPERIMENTAL
- label
- Group C: 16 ml/kg group
- interventionNames
- Drug: Ringer's solution acetate
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * 1\. ethnic Chinese; * 2\. age, 18 to 65 years old; * 3\. American Society of Anaesthesiologists (ASA) physical status I or II; * 4\. Daytime patients scheduled for general anesthesia Exclusion Criteria: * Patients unwilling to cooperate with the experiment * Body mass index exceeding 30 kg/m2; * Patients with a history of heart ,liver and Renal failure ,hypertension,diabetes mellitus or arteriosclerosis; and any allergy to drugs used in the study. * Patients with the urinary diseases, such as kidney, ureteral calculi and tumors, prostatic hypertrophy.
References
Publications (0)
Data not yet available
No reference posted for this study.